Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Stockholm-based Elekta secures €100 million EIB loan to advance cancer and neurological treatments.

PRIVATEAug 31, 2026•8 days ago

Amount Raised

€100 Million

Round Type

Debt Financing

SwedenOthermedical devices

Investors

European Investment Bank

Description

Elekta has secured a loan of up to €100 million from the European Investment Bank (EIB) to advance cancer and neurological treatments. This financing will support their research programme set to take place from 2026 to 2029. The loan will cover up to half of the total expected costs of €200 million. This investment aligns with EU objectives around health research and technological innovation.

Company Information

Company

Elekta

Location

10 Hagaesplanaden

Sweden

About

As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don't just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter. This information was brought to you by Cision http://news.cision.com https://news.cision.com/elekta/r/elekta-receives-initial-investment-grade-rating-from-s-p-global-ratings,c3440528 The following files are available for download: https://mb.cision.com/Main/35/3440528/1486502.pdf Sweden_New SP rating_2021_EN SOURCE Cision AB

Don't miss Elekta's next move

Get an email the moment Elekta raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Elekta's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Elekta raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.